News > Study reveals booster dose of Covid-19 increases resilience of antibody response

Study reveals booster dose of Covid-19 increases resilience of antibody response

Recent research from the University of Virginia School of Medicine discussed the benefits of a Covid-19 booster vaccine dose. The most recent study clarifies how Pfizer and Moderna mRNA boosters influence the persistence of our Covid-19 antibodies. The researchers previously found that after the primary vaccination series the antibodies generated by Pfizer's Covid-19 vaccine rose more slowly and declined more quickly than those generated by the Moderna vaccine.